SALIX PHARMACEUTICALS LTD·4

Mar 20, 4:43 PM ET

FRANCO RICHARD A 4

4 · SALIX PHARMACEUTICALS LTD · Filed Mar 20, 2012

Insider Transaction Report

Form 4
Period: 2012-03-16
Transactions
  • Sale

    Common Stock

    2012-03-16$51.98/sh9,375$487,31264,308 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    4,500
Footnotes (2)
  • [F1]The shares covered by this Form 4 have been sold pursuant to a Rule 10b5-1 Sales Plan dated March 5, 2012, which is intended to comply with Rule 10b5-1.
  • [F2]The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $51.53 to $52.39, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION